Ledger.Open graph →
SEC Form D · filed January 5, 2021

CARISMA Therapeutics Inc

Offering
$70.4M
Sold
$38.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Margarita Chavez · Philadelphia, PADirectorSuren Dutia · Franklin Lakes, NJDirectorBriggs Morrison · Cambridge, MADirectorSteven Kelly · Philadelphia, PAExec · DirectorChidozie Ugwumba · Philadelphia, PADirectorTony Padgett · San Antonio, TXDirectorRobert Scofield · San Antonio, TXDirectorBrennen Degner · PLAYA VISTA, CADirectorMadhav Krishna · Franklin Lakes, NJDirectorDan Rabinowitz · San Antonio, TXDirectorMike Kienitz · San Antonio, TXExec · DirectorMichael Heffernan · Canton, MADirectorMichael Heffernan · Cumberland, RIDirectorBriggs Morrison · Cambridge, MADirectorRegina Hodits · Philadelphia, PADirectorPatrick Reilly · Brighton, MAExec · DirectorJacob Gunterberg · Philadelphia, PADirectorChidozie Ugwumba · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗